A major new study reveals that drinking just two alcoholic beverages a day is associated with a 1 in 25 lifetime risk of death from alcohol-related causes, challenging the idea that moderate drinking is harmless.…
Early trial data from Memorial Sloan Kettering suggests a personalised mRNA therapy can dramatically improve outcomes for some patients and extend lifespans.